Silence Therapeutics
SLN
#6901
Rank
NZ$1.33 B
Marketcap
NZ$21.43
Share price
0.41%
Change (1 day)
149.50%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): NZ-$3.34

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.41. In 2025 the company made an earnings per share (EPS) of NZ-$3.31 a decrease over its 2024 EPS that were of NZ-$1.73.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.341.14%
2025NZ-$3.3190.91%
2024NZ-$1.73-32.65%
2023NZ-$2.57-5.77%
2022NZ-$2.73-13.03%
2021NZ-$3.1410.23%
2020NZ-$2.8558.5%
2019NZ-$1.802.94%
2018NZ-$1.74969.59%
2017NZ-$0.16-79.18%
2016NZ-$0.78-3.11%
2015NZ-$0.81-55%
2014NZ-$1.803.83%
2013NZ-$1.73-84.88%
2012NZ-$11.45134.19%
2011NZ-$4.89-61.8%
2010NZ-$12.80-45.65%
2009NZ-$23.55-1.16%
2008NZ-$23.824.29%
2007NZ-$22.8410.54%
2006NZ-$20.66-22.29%
2005NZ-$26.59-57.32%
2004NZ-$62.3039.1%
2003NZ-$44.7970.67%
2002NZ-$26.24-25.17%
2001NZ-$35.075.29%
2000NZ-$33.31-24.54%
1999NZ-$44.1426.7%
1998NZ-$34.84-11.73%
1997NZ-$39.4772.24%
1996NZ-$22.91